Combined application of class I antiarrhythmic drugs causes "additive", "reductive", or "synergistic" sodium channel block in cardiac muscles
- 1 November 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 24 (11) , 925-931
- https://doi.org/10.1093/cvr/24.11.925
Abstract
Study objective – The aim was to study the differences in cardiac sodium channel block among combinations of class I antiarrhythmic drugs. Design – Conventional glass microelectrode techniques were used to record transmembrane action potentials and their maximum upstroke velocity (dV/dtmax) reflecting the sodium channel availability, during treatment of the preparations with mexiletine (20, 40 μM) in combination with aprindine (5 μM), disopyramide (40 μM), and flecainide (5 μM). Experimental material – Guinea pig papillary muscles (n = 6-8 per experiment) were used for the study. Measurements and main results – In preparations constantly stimulated at 1 Hz, a shortening of action potential duration by aprindine was further enhanced, while prolongation by disopyramide or flecainide was reduced, after additional application of mexiletine. Trains of stimuli (0.5-2.0 Hz) were applied following a long quiescent period to evaluate “tonic” and “use dependent” decrease (block) of dV/dtmax. Additional application of mexiletine to the other three drugs resulted in ap enhancement of tonic block. Use dependent block by aprindine at 0.5-1.0 Hz was reduced by 8-9 after admixture of mexiletine, reflected in net increase in dV/dtmax at steady states (reductive effect). Dual exponential components of dV/dtmax recovery from use dependent block in presence of both drugs suggest their competitive interaction on a common receptor site associated with sodium channels. Use dependent block by flecainide at 0.5-2.0 Hz was increased (pmax was therefore largely inhibited by the drug combination (synergistic effect). Use dependent block in the presence of both disopyramide and mexiletine was similar to that predicted from the algebraic sum of each treatment. Conclusion – Combined application of class I antiarrhythmic drugs causes not only additive but also reductive or synergistic effects on dV/dtmax through modulation of use dependent block.Keywords
This publication has 15 references indexed in Scilit:
- Properties ofV max block of INa-mediated action potentials during combined application of antiarrhythmic drugs in cardiac muscleNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery diseaseThe American Journal of Cardiology, 1985
- Evidence for a specific receptor site for lidocaine, quinidine, and bupivacaine associated with cardiac sodium channels in guinea pig ventricular myocardium.Circulation Research, 1985
- Maximal upstroke velocity as an index of available sodium conductance. Comparison of maximal upstroke velocity and voltage clamp measurements of sodium current in rabbit Purkinje fibers.Circulation Research, 1984
- Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassificationCardiovascular Research, 1983
- Test of a model of antiarrhythmic drug action. Effects of quinidine and lidocaine on myocardial conduction.Circulation, 1980
- The relation of Vmax to INa, GNa, and h infinity in a model of the cardiac Purkinje fiberBiophysical Journal, 1979
- Validity of Vmax as a measure of the sodium current in cardiac and nervous tissuesBiophysical Journal, 1978
- Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channelsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1977
- Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction.The Journal of general physiology, 1977